Drug – bio-affecting and body treating compositions – Solid synthetic organic polymer as designated organic active... – Polymer from ethylenic monomers only
Patent
1979-10-01
1981-03-10
Fagelson, Anna P.
Drug, bio-affecting and body treating compositions
Solid synthetic organic polymer as designated organic active...
Polymer from ethylenic monomers only
424156, 424246, 424251, 424329, A61K 948, A61K 31505, A61K 3154
Patent
active
042554136
ABSTRACT:
A gelatin capsule unit dosage form containing triamterene, 2,4,7-triamino-6-phenylpteridine, which results in rapid dissolution of the active ingredient. The dosage form comprises the addition of a combination of a surfactant and a carbonate or bicarbonate salt as diluents.
REFERENCES:
patent: 3081230 (1963-03-01), Weinstock
Ravin et al., J. of Pharm. Sci., vol. 58, 1969, pp. 1242-1245.
Stewart et al., J. Pharm. Pharmacol. vol. 31, 1979 pp. 1-6.
Newton et al., J. Pharm. Pharmacol,. vol. 26(s) pp. 30P-36P.
Rattie Elisabeth S.
Ravin Louis J.
Fagelson Anna P.
Foggio Richard D.
Lourie Alan D.
Marlino Joseph A.
SmithKline Corporation
LandOfFree
Gelatin capsule dosage unit containing triamterene does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gelatin capsule dosage unit containing triamterene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gelatin capsule dosage unit containing triamterene will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1294073